Infection Surveillance Solutions Market Overview Analysis By Fortune Business Insights
Market Snapshot
According to Fortune Business Insights: The global infection surveillance solutions market was valued at USD 939.6 million in 2025 and is projected to grow from USD 1,040.1 million in 2026 to USD 2,381.8 million by 2034, exhibiting a CAGR of 10.91% during the forecast period. North America leads the global market, with the region valued at USD 421.2 million in 2025, supported by stringent infection control regulations and high healthcare IT adoption.
Infection surveillance solutions represent a critical segment of healthcare information technology, combining software platforms, advanced analytics, and data integration capabilities to help hospitals, long-term care facilities, and public health agencies monitor, detect, and prevent Healthcare-Associated Infections (HAIs) and infectious disease outbreaks. These solutions support patient safety improvements, regulatory compliance, and infection prevention team workflows across diverse care settings.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/112694
Market Drivers
Rising Prevalence of Healthcare-Associated Infections: HAIs remain a persistent and highly prevalent threat across care settings globally, creating urgent demand for automated, continuous surveillance capable of detecting CLABSI, CAUTI, SSI, C. difficile, and MRSA bacteremia signals at the earliest possible stage. The European Centre for Disease Prevention and Control (ECDC) highlighted in May 2025 that HAIs represent a major threat in European long-term care facilities, with more than 3.5 million HAI cases estimated annually across the EU/EEA. As patient acuity and invasive device utilization continue to rise, the need for sophisticated, real-time infection monitoring tools intensifies correspondingly across all care settings.
Regulatory and Reimbursement Pressure: In the U.S., HAI performance metrics are tied directly to hospital payment through the CMS Hospital-Acquired Condition (HAC) Reduction Program, which was updated in August 2025 to reinforce payment penalties linked to hospital-acquired conditions. This regulatory framework creates a compelling financial incentive for healthcare providers to invest in robust, automated surveillance infrastructure to protect both patient outcomes and revenue integrity.
Market Restraints & Challenges
High Implementation Costs and Limited IT Resources: Advanced infection surveillance systems require significant upfront investment in software licensing, hardware, EHR integration, and ongoing maintenance — a financial burden that many smaller or resource-constrained healthcare facilities struggle to absorb. Budget limitations often force providers to prioritize immediate clinical expenditures over digital surveillance modernization, slowing adoption particularly outside major acute care hospital systems.
EHR Integration Complexity: A critical operational challenge facing the market is the technical complexity of integrating surveillance platforms with diverse Electronic Health Records (EHR) environments. These solutions must reliably extract admission, discharge, and transfer (ADT) data, microbiology results, medication records, and device documentation from systems that vary widely across hospital sites. Data frequently arrives in inconsistent formats, requiring continuous mapping, normalization, and interface maintenance — adding operational overhead and increasing the risk of surveillance gaps.
Market Opportunities & Trends
Antimicrobial Resistance (AMR) Monitoring: Rising global attention to antimicrobial resistance is creating substantial market opportunity. Hospitals increasingly demand integrated AMR and HAI surveillance tools capable of continuously analyzing microbiology results, resistance phenotypes, and antibiotic use patterns to detect resistant organisms early, identify transmission clusters, and trigger isolation and stewardship workflows. In September 2025, the WHO launched an enhanced global AMR/AMU dashboard, reinforcing demand for hospitals to digitize and report standardized AMR and antibiotic-use data — a development that directly expands the addressable market for infection surveillance vendors.
AI and Machine Learning Integration: Embedding AI and machine learning into infection surveillance platforms is an emerging structural trend reshaping how HAI case-finding is conducted. Predictive models allow overburdened infection prevention teams to prioritize patients, units, and devices that carry the highest infection risk — replacing time-intensive manual chart reviews with automated, near real-time flagging. In April 2025, the University of Pittsburgh highlighted EDS-HAT, a machine learning model combined with genomic sequencing, capable of detecting hospital transmission patterns and guiding targeted infection-prevention action.
Segmentation Highlights
By Component: Software dominates, driven by higher hospital adoption rates, improved efficiency, and the accelerating shift to cloud-based delivery. The services segment is projected to grow at a CAGR of 9.88% through 2034, reflecting ongoing demand for implementation, training, and managed services.
By Surveillance Type: HAI surveillance leads with a 46.14% market share in 2026, anchored by its foundational role in infection detection and the broadest regulatory reporting burden. AMR & stewardship is the fastest-growing segment, expected to expand at a CAGR of 11.86%, driven by rising global AMR pressure.
By Deployment: Cloud/SaaS holds a 64.42% market share in 2026. Hospitals are increasingly preferring SaaS platforms for faster deployment, reduced IT maintenance overhead, and the ability to aggregate data across multiple facilities via enterprise dashboards. The on-premise segment continues to grow at a CAGR of 8.79%.
By End User: Acute care hospitals dominate with a 63.12% share in 2026, reflecting their high volumes of invasive procedures, ICU stays, and mandatory surveillance and reporting requirements. Private hospital networks are the fastest-growing end-user segment, with a CAGR of 12.03%.
Regional Outlook
Region
2025/2026 Value
Notes
North America
USD 421.2M (2025)
Largest share; U.S. leads at ~USD 424.4M in 2026
Europe
USD 274.1M (2026 est.)
CAGR of 9.94%; driven by national surveillance programs
Asia Pacific
USD 182.0M (2026 est.)
Third-largest; expanding healthcare infrastructure
Latin America & MEA
Nascent
Growing on rising infection cases and digitization
Germany (USD 50.3M) and the UK (USD 40.8M) lead within Europe, while China (USD 43.7M) and Japan (USD 32.6M) are the largest Asia Pacific contributors in 2026.
Competitive Landscape
The market is moderately consolidated, with Premier Inc., Oracle, BD, Wolters Kluwer N.V., Baxter, Epic Systems Corporation, RLDatix, and Clinisys as key profiled players. Wolters Kluwer's Sentri7 platform was named Best in KLAS for Infection Control & Monitoring in February 2025, while BD's HealthSight Infection Advisor continues to expand with updated workflow capabilities. Strategic partnerships, platform enhancements, and cloud-first product development remain the dominant competitive strategies across the sector.
Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/112694
Conclusion
The infection surveillance solutions market is entering a decade of accelerated growth, shaped by the dual imperatives of reducing the patient harm from HAIs and meeting increasingly stringent regulatory and reimbursement requirements. The convergence of AI-driven automation, AMR monitoring demand, and cloud-based scalability positions this market for sustained double-digit expansion through 2034, with innovation in integration and predictive analytics defining competitive differentiation.